Molecular imprinting-based separation methods for selective analysis of fluoroquinolones in soils

被引:117
作者
Turiel, Esther [1 ]
Martin-Esteban, Antonio [1 ]
Tadeo, Jose Luis [1 ]
机构
[1] Dept Med Ambiente, INIA, Madrid 28040, Spain
关键词
molecularly imprinted polymers; solid-phase extraction cartridges; screening; fluoroquinolones;
D O I
10.1016/j.chroma.2007.10.003
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Molecularly imprinted polymers (MlPs) for fluoroquinolone antibiotics (FQs) have been synthesised in one single preparative step by precipitation polymerisation using ciprofloxacin (CIP) as template. Combinations of methacrylic acid (MAA) or 4-vinylpyridine (VP) as functional monomers, ethylene glycol dimethacrylate as crosslinker and dichloromethane, methanol, acetonitrile or toluene as porogens were tested. The experiments carried out by molecularly imprinted solid-phase extraction (MISPE) in cartridges did not allow to detect any imprint effect in the VP-based polymers whereas it was clearly observed in the MAA-based polymers. Among them, the MIP prepared in methanol using MAA as monomer showed the best performance and was chosen for further experiments. The ability of the selected MIP for the selective recognition of other widely used FQs (enoxacin, norfloxacin, danofloxacin and enrofloxacin) and quinolones Qs) (cinoxacin, flumequine, nalidixic acid and oxolinic acid) was evaluated. The obtained results revealed the high selectivity of the obtained polymer, which was able to distinguish between FQs, that were recognised and retained onto the MIP cartridge, and Qs, which were washed out during loading and washing steps. The MIP was then packed into a stainless steel column (50 mm x 4.6 mm i.d.) and evaluated as chromatography column for screening of FQs in soil samples. The mobile phase composition, flow rate, and the elution profile were then optimised in order to improve peak shape without sacrifying imprinting factor. Finally, under optimised conditions, soil samples spiked with CIP or with a mixture of fluoroquinolones in concentration of 0.5 Lg g- I were successfully analysed by the developed MIP-based procedures. (c) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:97 / 104
页数:8
相关论文
共 26 条
[1]   Selected drugs in solid matrices: a review of environmental determination, occurrence and properties of principal substances [J].
Beausse, J .
TRAC-TRENDS IN ANALYTICAL CHEMISTRY, 2004, 23 (10-11) :753-761
[2]   Uptake of veterinary medicines from soils into plants [J].
Boxall, ABA ;
Johnson, P ;
Smith, EJ ;
Sinclair, CJ ;
Stutt, E ;
Levy, LS .
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2006, 54 (06) :2288-2297
[3]   Fluoroquinolones in animal health [J].
Brown, SA .
JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 1996, 19 (01) :1-14
[4]   Novel enrofloxacin imprinted polymer applied to the solid-phase extraction of fluorinated quinolones from urine and tissue samples [J].
Caro, E ;
Marcé, RM ;
Cormack, PAG ;
Sherrington, DC ;
Borrull, F .
ANALYTICA CHIMICA ACTA, 2006, 562 (02) :145-151
[5]   Determination of antibiotic residues in manure, soil, and surface waters [J].
Christian, T ;
Schneider, RJ ;
Färber, HA ;
Skutlarek, D ;
Meyer, MT ;
Goldbach, HE .
ACTA HYDROCHIMICA ET HYDROBIOLOGICA, 2003, 31 (01) :36-44
[6]   Pharmaceuticals and personal care products in the environment: Agents of subtle change? [J].
Daughton, CG ;
Ternes, TA .
ENVIRONMENTAL HEALTH PERSPECTIVES, 1999, 107 :907-938
[7]   Environmental behavior and analysis of veterinary and human drugs in soils, sediments and sludge [J].
Díaz-Cruz, MS ;
de Alda, MJL ;
Barceló, D .
TRAC-TRENDS IN ANALYTICAL CHEMISTRY, 2003, 22 (06) :340-351
[8]   Fate and mobility of pharmaceuticals in solid matrices [J].
Drillia, P ;
Stamatelatou, K ;
Lyberatos, G .
CHEMOSPHERE, 2005, 60 (08) :1034-1044
[9]   Improved liquid chromatographic determination of nine currently used (fluoro)quinolones with fluorescence and mass spectrometric detection for environmental samples [J].
Ferdig, M ;
Kaleta, A ;
Buchberger, W .
JOURNAL OF SEPARATION SCIENCE, 2005, 28 (13) :1448-1456
[10]  
GAU W, 1986, ARZNEIMITTEL-FORSCH, V36-2, P1545